G13.0 – Paraneoplastic neuromyopathy and neuropathy
ICD-10-CM 2027 diagnosis code · Systemic atrophies primarily affecting the central nervous system
ICD-10-CM code
G13.0
- Code
G13.0(claims format:G130)- Description
- Paraneoplastic neuromyopathy and neuropathy
- Billable
- Yes – valid for HIPAA-covered transactions
- Valid for
- Dates of service October 1, 2026 – September 30, 2027 (FY2027)
- Chapter
- 6. Diseases of the nervous system (G00-G99)
- Block
- G10-G14 Systemic atrophies primarily affecting the central nervous system
- Parent codes
- G13
Notes for G13.0
Applicable to:
- Carcinomatous neuromyopathy
- Sensorial paraneoplastic neuropathy [Denny Brown]
Index terms for G13.0
Entries in the ICD-10-CM alphabetic index that lead to this code:
Related codes in G13
- G13.1 – Other systemic atrophy primarily affecting central nervous system in neoplastic diseaseBillable
- G13.2 – Systemic atrophy primarily affecting the central nervous system in myxedemaBillable
- G13.8 – Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhereBillable
Frequently asked questions
What is ICD-10 code G13.0?
G13.0 is the ICD-10-CM code for paraneoplastic neuromyopathy and neuropathy, in the block G10-G14 (Systemic atrophies primarily affecting the central nervous system).
Is G13.0 a billable code?
Yes. G13.0 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.
What category does G13.0 belong to?
It belongs to category G13 – Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere.
Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.